-
Loading metrics
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting
- Amy P. Abernethy,
- Ashwini Arunachalam,
- Thomas Burke,
- Caroline McKay,
- Xiting Cao,
- Rachael Sorg,
- David P. Carbone
x
- Published: June 23, 2017
- https://doi.org/10.1371/journal.pone.0178420